Great Point Partners LLC Nektar Therapeutics Transaction History

Great Point Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $8.21 Million - $13.9 Million	-2,702,180 Reduced 85.78%	447,820 $1.43 Million
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $8.39 Million - $16.3 Million	2,645,309 Added 524.14%	3,150,000 $12 Million
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $6.6 Million - $9.51 Million	504,691 New	504,691 $9.06 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $33.7 Million - $49.1 Million	-2,125,000 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$16.91 - $36.27 $35.9 Million - $77.1 Million	2,125,000 New	2,125,000 $38.7 Million

152

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.